IRLAB Therapeutics AB (publ) (STO: IRLAB.A)
Sweden
· Delayed Price · Currency is SEK
14.40
-0.15 (-1.03%)
Aug 30, 2024, 5:29 PM CET
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 746.91 million as of August 30, 2024. Its market cap has increased by 92.00% in one year.
Market Cap
746.91M
Enterprise Value
703.86M
Revenue
41.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.40
Market Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has increased from 413.00M to 746.91M, an increase of 80.85%. That is a compound annual growth rate of 8.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca PLC | 2,774.87B |
ABB Ltd | 1,084.57B |
Investor AB (publ) | 933.86B |
Investor AB (publ) | 933.86B |
Atlas Copco AB | 871.62B |
Atlas Copco AB | 871.62B |
AB Volvo (publ) | 555.92B |
AB Volvo (publ) | 555.92B |